Clinical Spectrum of POLR3-related Leukodystrophy Caused by Biallelic Pathogenic Variants

Objective: To determine the clinical, radiologic, and molecular characteristics of RNA polymerase III-related leukodystrophy (POLR3-HLD) caused by biallelic pathogenic variants.

Methods: A cross-sectional observational study involving 25 centers worldwide was conducted. Clinical and molecular information was collected on 23 unreported and previously reported patients with POLR3-HLD and biallelic pathogenic variants in . Brain MRI studies were reviewed.

Results: Fourteen female and 9 male patients aged 7 days to 23 years were included in the study. Most participants presented early in life (birth to 6 years), and motor deterioration was seen during childhood. A notable proportion of patients required a wheelchair before adolescence, suggesting a more severe phenotype than previously described in POLR3-HLD. Dental, ocular, and endocrine features were not invariably present (70%, 50%, and 50%, respectively). Five patients (22%) had a combination of hypomyelinating leukodystrophy and abnormal craniofacial development, including 1 individual with clear Treacher Collins syndrome (TCS) features. Brain MRI revealed hypomyelination in all cases, often with areas of pronounced T2 hyperintensity corresponding to T1 hypointensity of the white matter. Twenty-nine different pathogenic variants (including 12 new disease-causing variants) in were identified.

Conclusions: This study provides a comprehensive description of POLR3-HLD caused by biallelic pathogenic variants based on the largest cohort of patients to date. These results suggest distinct characteristics of POLR1C-related disorder, with a spectrum of clinical involvement characterized by hypomyelinating leukodystrophy with or without abnormal craniofacial development reminiscent of TCS.

Citing Articles

Stress and Quality of Life of Parents of Children With POLR3-Related Leukodystrophy: A Cross-Sectional Pilot Study.

Lentini L, Toutounchi H, Chapleau A, Le A, Fournier S, Emari F J Child Neurol. 2024; 40(1):26-38.

PMID: 39429022 PMC: 11590388. DOI: 10.1177/08830738241283171.

Liu J, Niu Y, Qin J, Yang Z Front Neurol. 2024; 15:1355484.

PMID: 38550343 PMC: 10972892. DOI: 10.3389/fneur.2024.1355484.

Biallelic pathogenic variants in alter tRNA transcription and cause a hypomyelinating leukodystrophy: A case report.

Macintosh J, Perrier S, Pinard M, Tran L, Guerrero K, Prasad C Front Neurol. 2023; 14:1254140.

PMID: 37915380 PMC: 10616956. DOI: 10.3389/fneur.2023.1254140.

Hypomyelination, hypodontia and craniofacial abnormalities in a Polr3b mouse model of leukodystrophy.

Michell-Robinson M, Watt K, Grouza V, Macintosh J, Pinard M, Tuznik M Brain. 2023; 146(12):5070-5085.

PMID: 37635302 PMC: 10690025. DOI: 10.1093/brain/awad249.

Uncertain significance mutation in the POLR3B gene in a Syrian boy with leukodystrophy: a case report.

Hamdan Z, Alasmar D Ann Med Surg (Lond). 2023; 85(8):4126-4130.

PMID: 37554900 PMC: 10406027. DOI: 10.1097/MS9.0000000000001033.

References

Tetreault M, Choquet K, Orcesi S, Tonduti D, Balottin U, Teichmann M . Recessive mutations in POLR3B, encoding the second largest subunit of Pol III, cause a rare hypomyelinating leukodystrophy. Am J Hum Genet. 2011; 89(5):652-5. PMC: 3213403. DOI: 10.1016/j.ajhg.2011.10.006. View

Potic A, Brais B, Choquet K, Schiffmann R, Bernard G . 4H syndrome with late-onset growth hormone deficiency caused by POLR3A mutations. Arch Neurol. 2012; 69(7):920-3. DOI: 10.1001/archneurol.2011.1963. View

Schlump J, Stein A, Hehr U, Karen T, Moller-Hartmann C, Elcioglu N . Treacher Collins syndrome: clinical implications for the paediatrician--a new mutation in a severely affected newborn and comparison with three further patients with the same mutation, and review of the literature. Eur J Pediatr. 2012; 171(11):1611-8. DOI: 10.1007/s00431-012-1776-7. View

La Piana R, Cayami F, Tran L, Guerrero K, Van Spaendonk R, Ounap K . Diffuse hypomyelination is not obligate for POLR3-related disorders. Neurology. 2016; 86(17):1622-6. PMC: 4844237. DOI: 10.1212/WNL.0000000000002612. View

Eldomery M, Coban-Akdemir Z, Harel T, Rosenfeld J, Gambin T, Stray-Pedersen A . Lessons learned from additional research analyses of unsolved clinical exome cases. Genome Med. 2017; 9(1):26. PMC: 5361813. DOI: 10.1186/s13073-017-0412-6. View

Steenweg M, Vanderver A, Blaser S, Bizzi A, De Koning T, Mancini G . Magnetic resonance imaging pattern recognition in hypomyelinating disorders. Brain. 2010; 133(10):2971-82. PMC: 3589901. DOI: 10.1093/brain/awq257. View

Teber O, Gillessen-Kaesbach G, Fischer S, Bohringer S, Albrecht B, Albert A . Genotyping in 46 patients with tentative diagnosis of Treacher Collins syndrome revealed unexpected phenotypic variation. Eur J Hum Genet. 2004; 12(11):879-90. DOI: 10.1038/sj.ejhg.5201260. View

Wolf N, Vanderver A, van Spaendonk R, Schiffmann R, Brais B, Bugiani M . Clinical spectrum of 4H leukodystrophy caused by POLR3A and POLR3B mutations. Neurology. 2014; 83(21):1898-905. PMC: 4248461. DOI: 10.1212/WNL.0000000000001002. View

La Piana R, Tonduti D, Dressman H, Schmidt J, Murnick J, Brais B . Brain magnetic resonance imaging (MRI) pattern recognition in Pol III-related leukodystrophies. J Child Neurol. 2013; 29(2):214-20. DOI: 10.1177/0883073813503902. View

10.

Vanderver A, Prust M, Tonduti D, Mochel F, Hussey H, Helman G . Case definition and classification of leukodystrophies and leukoencephalopathies. Mol Genet Metab. 2015; 114(4):494-500. PMC: 4390457. DOI: 10.1016/j.ymgme.2015.01.006. View

11.

Paolacci S, Li Y, Agolini E, Bellacchio E, Arboleda-Bustos C, Carrero D . Specific combinations of biallelic variants cause Wiedemann-Rautenstrauch syndrome. J Med Genet. 2018; 55(12):837-846. DOI: 10.1136/jmedgenet-2018-105528. View

12.

Cayami F, Bugiani M, Pouwels P, Bernard G, van der Knaap M, Wolf N . 4H Leukodystrophy: Lessons from 3T Imaging. Neuropediatrics. 2017; 49(2):112-117. DOI: 10.1055/s-0037-1608780. View

13.

Dorboz I, Dumay-Odelot H, Boussaid K, Bouyacoub Y, Barreau P, Samaan S . Mutation in causes hypomyelinating leukodystrophy and abnormal ribosomal RNA regulation. Neurol Genet. 2018; 4(6):e289. PMC: 6283457. DOI: 10.1212/NXG.0000000000000289. View

14.

Thiffault I, Wolf N, Forget D, Guerrero K, Tran L, Choquet K . Recessive mutations in POLR1C cause a leukodystrophy by impairing biogenesis of RNA polymerase III. Nat Commun. 2015; 6:7623. PMC: 4506509. DOI: 10.1038/ncomms8623. View

15.

Neyer S, Kunz M, Geiss C, Hantsche M, Hodirnau V, Seybert A . Structure of RNA polymerase I transcribing ribosomal DNA genes. Nature. 2016; 540(7634):607-610. DOI: 10.1038/nature20561. View

16.

Vincent M, Genevieve D, Ostertag A, Marlin S, Lacombe D, Martin-Coignard D . Treacher Collins syndrome: a clinical and molecular study based on a large series of patients. Genet Med. 2015; 18(1):49-56. DOI: 10.1038/gim.2015.29. View

17.

Dauwerse J, Dixon J, Seland S, Ruivenkamp C, van Haeringen A, Hoefsloot L . Mutations in genes encoding subunits of RNA polymerases I and III cause Treacher Collins syndrome. Nat Genet. 2010; 43(1):20-2. DOI: 10.1038/ng.724. View

18.

Parikh S, Bernard G, Leventer R, van der Knaap M, Van Hove J, Pizzino A . A clinical approach to the diagnosis of patients with leukodystrophies and genetic leukoencephelopathies. Mol Genet Metab. 2015; 114(4):501-515. PMC: 4390485. DOI: 10.1016/j.ymgme.2014.12.434. View

19.

Daoud H, Tetreault M, Gibson W, Guerrero K, Cohen A, Gburek-Augustat J . Mutations in POLR3A and POLR3B are a major cause of hypomyelinating leukodystrophies with or without dental abnormalities and/or hypogonadotropic hypogonadism. J Med Genet. 2013; 50(3):194-7. DOI: 10.1136/jmedgenet-2012-101357. View

20.

Fernandez-Tornero C, Moreno-Morcillo M, Rashid U, Taylor N, Ruiz F, Gruene T . Crystal structure of the 14-subunit RNA polymerase I. Nature. 2013; 502(7473):644-9. DOI: 10.1038/nature12636. View